Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Dev Regulatory News (FDEV)

Share Price Information for Frontier Dev (FDEV)

Share Price is delayed by 15 minutes
Get Live Data
461.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 4.50 (0.988%)
Market Cap: £160.29m
FDEV Live PriceLast checked at - London Stock Exchange

Intraday Frontier Dev Share Chart

Elite: Dangerous Alpha testing commences

12 Dec 2013 07:00

RNS Number : 3357V
Frontier Developments PLC
12 December 2013
 



12 December 2013

 

Frontier Developments plc 

 

Elite: Dangerous Alpha testing process commences

 

Frontier Developments plc (AIM: FDEV, "Frontier," the "Company"), a leading developer of video games with studios in Cambridge, UK and Halifax, Canada, announces the commencement on schedule of the Elite: Dangerous Alpha phase for eligible backers today.

 

This follows Frontier's announcement on 18 October 2013 that the Alpha phase would launch in December 2013.

 

At the end of 2012, Frontier raised £1.6 million via Kickstarter, the crowd funding service, and via its own website. The funds were raised specifically to develop Elite: Dangerous - the latest sequel to the Elite game that CEO David Braben originally co-authored published in 1984. Backers eligible to access the Alpha test phase in December 2013 are those who contributed £200 or more to develop Elite: Dangerous.

 

Alpha Phase One - Single Player Combat is a series of single player combat scenarios designed to test the combat systems in a close-to-final form. The Alpha Phase One process will give eligible backers an opportunity to test these aspects of the game and comment on the user experience.

 

David Braben, CEO of Frontier Developments, said:

 

"Starting the Elite: Dangerous Alpha process on schedule is a significant milestone for Frontier. Involving our backers from this stage of the development will give us access to valuable feedback that we will use to ensure the released game is as polished as possible."

 

 

Enquiries:

 

Frontier Developments

+44 (0)1223 394 300

David Braben, CEO

David Walsh, COO

Neil Armstrong, CFO

Canaccord Genuity 

+44 (0) 207 523 8000

Simon Bridges/Cameron Duncan

College Hill

+44 (0) 20 7457 2020

Kay Larsen/Adrian Duffield

 

 

About Frontier Developments

 

Frontier Developments plc is a leading independent game developer founded in 1994 by David Braben, co-author of the seminal 'Elite' game. Based in Cambridge, UK and Halifax, Nova Scotia, Canada, Frontier uses its proprietary 'Cobra' game development technology to create innovative games across videogame consoles, computers, smartphones and tablets.

 

Previous titles Frontier has created on include RollerCoaster Tycoon 3, Thrillville, LostWinds, Kinectimals, Kinect Disneyland Adventures. On 4 January 2013 Frontier raised £1.7 million via Kickstarter, the crowd funding website, and its own site to develop Elite: Dangerous. The studio is also working on a number of other titles, including Zoo Tycoon as a launch title for Microsoft's new Xbox One console.

 

 www.frontier.co.uk

 

 

About Cobra

Frontier's Cobra software technology has been developed and evolved since 1988. Initially conceived as a solution for the problem of easily porting the same game across different target hardware devices, Cobra today supports multi-core CPU and GPU architectures of PC, console, tablet and smartphone with a modular, high performance system offering of state of the art efficiency and visual fidelity that is applicable across a wide range of game genres.

 

Cobra incorporates a framework which enables rapid development of powerful game creation tools, which offer the ability to view, tweak and review changes to content (e.g. animations, audio, 3D models etc.) on target platforms in a live game session running on that platform, without the intervention of a programmer.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBIBDDRGBBGXB
Date   Source Headline
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSDirector/PDMR Shareholding
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSDirector/PDMR Shareholding
17th Mar 20267:00 amRNSDirector/PDMR Shareholding
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSDirector/PDMR Shareholding
13th Mar 20267:00 amRNSDirector/PDMR Shareholding
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSDirector/PDMR Shareholding
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSDirector/PDMR Shareholding
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSDirector/PDMR Shareholding
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSDirector/PDMR Shareholding
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSDirector/PDMR Shareholding
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSDirector/PDMR Shareholding
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSDirector/PDMR Shareholding
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSLaunch of on-market Share Buyback Programme
26th Feb 20267:00 amRNSBlock Listing Return
11th Feb 202610:45 amRNSOption Grants / PDMR Dealings
27th Jan 20263:43 pmRNSHolding(s) in Company
14th Jan 20267:00 amRNSExcellent H1 Results & full year outlook upgraded
2nd Jan 20267:00 amRNSAppointment of Chief Executive Officer
2nd Jan 20267:00 amRNSAppointment of Chief Executive Officer
16th Dec 20257:00 amRNSCEO TRANSITION
14th Nov 20251:37 pmRNSDirector/PDMR Shareholding
6th Nov 20257:00 amRNSA STRONG LAUNCH FOR JWE3 & A SEQUEL FOR PLANET ZOO
5th Nov 20258:57 amRNSHolding(s) in Company
29th Oct 202510:48 amRNSResult of AGM
21st Oct 20253:00 pmRNS-RJURASSIC WORLD EVOLUTION 3 IS OUT NOW!

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.